1407 |
Beyond FAME: The Integration of Invasive Ischemia Assessment(FFR) into Clinical Practice |
William F. Fearon |
May. 12. 11 |
1406 |
DES in Left Main Disease: New Guidelines and Updates from EXCEL |
Gregg W. Stone |
May. 12. 11 |
1405 |
The NEW Anti-platelet Agents and Platelet Reactivity Testing: Recommendations for Prasugrel and Ticagrelor and Lessons from GRAVATAS |
Roxana Mehran |
May. 12. 11 |
1404 |
SES Revisited: The ¡°Unexpected¡± Results and Clinical Implications from BASKET-PROVE, SORT-OUT IV, and ISAR-TEST 4 |
David E. Kandzari |
May. 12. 11 |
1403 |
Complications after TAVI: VARC Definitions, Frequency, and Management Considerations |
Patrick W. Serruys |
May. 12. 11 |
1402 |
TAVI Perspectives from the European Theatre: New Indications and Multiple Devices |
Eberhard Grube |
May. 12. 11 |
1401 |
Life after PARTNER (Inoperable and ¡°High Risk¡± Cohorts): Will TAVI Therapy Change Guidelines for AS Patients? |
Martin Bert Leon |
May. 12. 11 |
1400 |
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease |
Seung-Jung Park |
Apr. 08. 11 |
1399 |
Take Home Message with Special Lecture |
Seung-Whan Lee |
Jan. 11. 11 |
1398 |
Wire Crossing Technique in Antegrade Approach [1] |
Takahiko Suzuki |
Jan. 11. 11 |